- Home
- XPO vs DVA Comparison
XPO vs DVA Comparison
Compare XPO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPO
- DVA
- Stock Information
- Founded
- XPO 2000
- DVA 1994
- Country
- XPO United States
- DVA United States
- Employees
- XPO N/A
- DVA N/A
- Industry
- XPO Transportation Services
- DVA Misc Health and Biotechnology Services
- Sector
- XPO Consumer Discretionary
- DVA Health Care
- Exchange
- XPO Nasdaq
- DVA Nasdaq
- Market Cap
- XPO 15.8B
- DVA 12.6B
- IPO Year
- XPO N/A
- DVA 1995
- Fundamental
- Price
- XPO $137.54
- DVA $166.24
- Analyst Decision
- XPO Buy
- DVA Hold
- Analyst Count
- XPO 17
- DVA 5
- Target Price
- XPO $149.71
- DVA $153.40
- AVG Volume (30 Days)
- XPO 1.6M
- DVA 683.8K
- Earning Date
- XPO 02-06-2025
- DVA 02-11-2025
- Dividend Yield
- XPO N/A
- DVA N/A
- EPS Growth
- XPO 895.80
- DVA 41.03
- EPS
- XPO 3.08
- DVA 9.24
- Revenue
- XPO $8,090,000,000.00
- DVA $12,666,614,000.00
- Revenue This Year
- XPO $5.36
- DVA $6.18
- Revenue Next Year
- XPO $4.02
- DVA $3.58
- P/E Ratio
- XPO $44.75
- DVA $17.98
- Revenue Growth
- XPO 5.96
- DVA 6.34
- 52 Week Low
- XPO $82.51
- DVA $103.40
- 52 Week High
- XPO $161.00
- DVA $169.52
- Technical
- Relative Strength Index (RSI)
- XPO 47.00
- DVA 69.32
- Support Level
- XPO $130.34
- DVA $151.10
- Resistance Level
- XPO $140.09
- DVA $154.05
- Average True Range (ATR)
- XPO 4.07
- DVA 3.44
- MACD
- XPO 0.38
- DVA 1.81
- Stochastic Oscillator
- XPO 60.09
- DVA 98.58
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. On a pro forma basis for the RXO spinoff, We estimate LTL shipping now makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.